PAR VALUE PER SHARE. For VALUE RECEIVED, [ ] (“Warrantholder”), is entitled to purchase, subject to the provisions of this Warrant, from Artisoft, Inc., a Delaware corporation (“Company”), at any time not later than 5:00 P.M., Eastern time, on the Expiration Date, at an exercise price per share equal to $4.00 (the exercise price in effect being herein called the “Warrant Price”), shares (“Warrant Shares”) of Common Stock (as defined below). The number of Warrant Shares purchasable upon exercise of this Warrant and the Warrant Price shall be subject to adjustment from time to time as described herein. As used herein, “
PAR VALUE PER SHARE. The Trustees may authorize separate classes of Shares together with such designations and powers, preferences and rights, qualifications, limitations and restrictions may be determined from time to time by the Board of Trustees. The number of shares of beneficial interest authorized hereunder is unlimited. The Trustees shall have the authority from time to time to establish and designate one or more separate, distinct and independent Series of Shares (each of which Series, including without limitation each Series authorized in Section 6.1(b) hereof, shall represent interests only in the assets attributed by the Trustees to such Series), and to authorize separate Classes of Shares of any such Series, as they deem necessary or desirable.
PAR VALUE PER SHARE. UNDERWRITING AGREEMENT November __, 1999 Goldxxx, Xxchx & Xo. Credit Suisse First Boston Morgxx Xxxnxxx & Xo. Incorporated First Union Securities, Inc. Friedman, Billings, Ramsxx & Xo., Inc. As representatives of the several Underwriters named in Schedule I hereto, c/o Goldman, Sachx & Xo. 85 Bxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 Xxdies and Gentlemen: Sapient Corporation, a Delaware corporation (the "Company"), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the "Underwriters") an aggregate of 1,114,600 shares of Common Stock, $.01 par value per share ("Stock") of the Company, and the stockholders of the Company named in Schedule II hereto (the "Selling Stockholders") propose, subject to the terms and conditions stated herein, to sell to the Underwriters an aggregate of 2,385,400 shares and, at the election of the Underwriters, Jerrx X. Xxxxxxxxx, X. Stuaxx Xxxxx, xxe J. Stuaxx Xxxxx Xxxainder Trust and the J. Stuaxx Xxxxx Xxxt Trust (collectively, the "Principal Selling Stockholders"), propose, subject to the terms and conditions stated herein, to sell an aggregate of an additional 525,000 shares. The aggregate of 3,500,000 shares to be sold by the Company and the Selling Stockholders is herein called the "Firm Shares" and the aggregate of 525,000 additional shares to be sold by the Principal Selling Stockholders is herein called the "Optional Shares". The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the "Shares".
PAR VALUE PER SHARE. The par value of shares issued by the Company shall be five thousand Won (Won 5,000) per share.
PAR VALUE PER SHARE. This Certifies that ________________________________ is the registered holder of _______________________________________________________________ Shares Common Stock of EMPIRE FINANCIAL HOLDING COMPANY transferable only on the books of the Corporation by the holder hereof in person or by Attorney upon surrender of this Certificate properly endorsed.
PAR VALUE PER SHARE. PLACEMENT AGENCY AGREEMENT -------------------------- August 21, 2001 BEAR, XXXXXXX & CO. INC. As Placement Agent 000 Xxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Dear Sir or Madam: You have approached EMD, Inc., a Delaware corporation, Genpharm Inc., a corporation organized under the laws of Ontario, and Merck KGaA, a Kommanditgesellschaft auf Aktein organized under the laws of Germany (each, a "Selling Stockholder," and collectively, the "Selling Stockholders"), to determine whether the Selling Stockholders would be interested in selling 13,634,012 shares (the "Shares") of common stock, par value $0.01 per share (the "Common Stock"), of Pharmaceutical Resources, Inc., a New Jersey corporation (the "Company"), beneficially owned by the Selling Stockholders, to certain Investors (as defined below). The Selling Stockholders have informed you that no decision has been made by them to sell the Shares, but that if the Selling Stockholders were to receive offers to purchase the Shares on terms and conditions, including price, deemed acceptable to the Selling Stockholders, the Selling Stockholders may determine to sell the Shares, subject to obtaining necessary internal corporate approvals by the Selling Stockholders. You have provided the Selling Stockholders with offers from Investors to purchase the Shares on terms and conditions that the Selling Stockholders are considering accepting. The Selling Stockholders desire to engage you, and any sub-agent designated by you, as their placement agent (the "Placement Agent") in connection with the possible sale of the Shares to the Investors. The Shares are more fully described in the Registration Statement (as hereinafter defined). The Company and the Selling Stockholders hereby confirm as follows their agreements with the Placement Agent.
PAR VALUE PER SHARE. It is hereby certified that:
PAR VALUE PER SHARE. In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of a Statement on Schedule 13G and any and all amendments thereto, with respect to the above referenced securities and that this Agreement be included as an Exhibit to such filing. This Agreement may be executed in any number of counterparts each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement.
PAR VALUE PER SHARE. For VALUE RECEIVED, [ ] (“Warrantholder”), is entitled to purchase, subject to the provisions of this Warrant, from Artisoft, Inc., a Delaware corporation (“Company”), at any time not later than 5:00 P.M., Eastern time, on the Expiration Date, at an exercise price per share equal to [$ - blank to be filled with the greater of (i) $1.88 per share or (ii) the per share closing sale price of the Common Stock on the Nasdaq SmallCap Market on the market close immediately preceding the execution of the Purchase Agreement] (the exercise price in effect being herein called the “Warrant Price”), [ ] shares (“Warrant Shares”) of Common Stock (as defined below). The number of Warrant Shares purchasable upon exercise of this Warrant and the Warrant Price shall be subject to adjustment from time to time as described herein. As used herein, “
PAR VALUE PER SHARE. This is to certify that, FOR VALUE RECEIVED, (“Warrantholder”), is entitled to purchase, subject to the provisions of this Warrant, from HARKEN ENERGY CORPORATION, a corporation organized under the laws of Delaware (“Company”), at any time and from time to time after the issuance hereof but not later than 5:00 P.M., Eastern time, on the second (2nd) anniversary (“Expiration Date”) of the date on which the Registration Statement (as defined in the Registration Rights Agreement) covering the resale of the Warrant Shares is declared effective by the SEC, shares (“Warrant Shares”) of Common Stock, $0.01 par value (“Common Stock”), of the Company, at an exercise price per share equal to $0.68 (the exercise price in effect from time to time hereafter being herein called the “Warrant Price”). The number of Warrant Shares purchasable upon exercise of this Warrant and the Warrant Price shall be subject to adjustment from time to time as described herein. This Warrant has been issued pursuant to the terms of the Purchase Agreement (“Purchase Agreement”) dated on or about the date hereof between the Company and the Warrantholder. Capitalized terms used herein and not defined shall have the meaning specified in the Purchase Agreement.
